Loading...

Schrodinger Inc
NASDAQ:SDGR

Watchlist Manager
Schrodinger Inc Logo
Schrodinger Inc
NASDAQ:SDGR
Watchlist
Price: 16.49 USD +0.37% Market Closed
Updated: Dec 10, 2022

Intrinsic Value

The intrinsic value of one SDGR stock under the Base Case scenario is 16.87 USD. Compared to the current market price of 16.49 USD, Schrodinger Inc is Undervalued by 2%.

The Intrinsic Value is calculated as the average of the two valuation methods:

SDGR Intrinsic Value
Base Case
16.87 USD
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

SDGR Profitability Score
Profitability Due Diligence

Schrodinger Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROIC
Negative 3-Year Average ROE
Negative Free Cash Flow
Negative Operating Income
29/100
Profitability
Score

Schrodinger Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

SDGR Solvency Score
Solvency Due Diligence

Schrodinger Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Long-Term Liabilities
Short-Term Liabilities
Low D/E
High Altman Z-Score
77/100
Solvency
Score

Schrodinger Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
52%
Gross Margin
-83%
Operating Margin
-90%
Net Margin
-60%
FCF Margin
-28%
ROE
-86%
ROIC
Other

SDGR Capital Structure
Schrodinger Inc

Market Capitalization 1.2B USD
Total Debt 0 USD
Minority Interest 15k USD
Preferred Equity 0 USD
Cash and Equivalents 127M USD
Short-Term Investments 382M USD
Enterprise Value 664M USD

Wall St
Price Targets

SDGR Price Targets Summary
Schrodinger Inc

Wall Street analysts forecast SDGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SDGR is 62.22 USD with a low forecast of 37.37 USD and a high forecast of 90.3 USD.

Lowest
Price Target
37.37 USD
127% Upside
Average
Price Target
62.22 USD
277% Upside
Highest
Price Target
90.3 USD
448% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

SDGR Competitors
Schrodinger Inc

SDGR Suppliers & Customers
Schrodinger Inc

Schrodinger Inc has 13 key suppliers from 6 countries and 6 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Pharmaceuticals industry.

Schrodinger Inc has 11 key customers from 6 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Pharmaceuticals industry.

Ownership

SDGR Insider Trading
Buy and sell transactions by insiders

Schrodinger Inc insiders have only sold shares in the past 12 months.

During the last 12 months Schrodinger Inc insiders have not bought any shares, and sold 173k USD worth of shares. The last transaction was made on Dec 10, 2022 by Thornberry Nancy (Director), who sold 173k USD worth of SDGR shares.

Sold
0-3
months
0 USD
0
3-6
months
173k USD
1
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
N/A
N/A
6 Months
173k USD
N/A
-173.3k
9 Months
173k USD
N/A
-173.3k
12 Months
173k USD
N/A
-173.3k
Purchases
3
Sales
203
Why is insider trading important?

Shareholder Return

SDGR Price
Schrodinger Inc

1M 1M
-24%
6M 6M
-34%
1Y 1Y
-55%
3Y 3Y
-42%
5Y 5Y
-42%
Annual Price Range
16.49
52w Low
16.24
52w High
38.19
Price Metrics
Average Annual Return 177.51%
Standard Deviation of Annual Returns
N/A
Max Drawdown -86%
Shares Statistics
Market Capitalization 1.2B USD
Shares Outstanding 71 207 992
Percentage of Shares Shorted 6.69%

Company Profile

Schrodinger Inc

Country

United States of America

Industry

Health Care

Market Cap

1.2B USD

Dividend Yield

0%

Description

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 664 full-time employees. The company went IPO on 2020-02-06. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Company’s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. The Company’s physics-based software platform enables discovery of molecules for drug development and materials applications. Its software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories. The Company’s pipeline includes CDC7, Wee1, MALT1, HIF-2 alpha and SOS1/KRAS. Its CDC7 is a small molecule inhibitor for treatment of solid and liquid tumors.

Contact

NEW YORK
New York City
1540 Broadway, 24Th Floor
+15032991150.0
https://www.schrodinger.com

IPO

2020-02-06

Employees

664

Officers

CEO, Pres & Director
Dr. Ramy Farid Ph.D.
Co-Founder, Scientific Advisory Chairman and Director
Dr. Richard A. Friesner Ph.D.
Exec. VP & CTO
Mr. Kenneth Patrick Lorton
Exec. VP, Chief Computational Scientist and Head of Modeling R&D
Dr. Robert Lorne Abel Ph.D.
Pres of R&D Therapeutics
Dr. Karen Akinsanya Ph.D.
Co-Founder & Scientific Advisor
Prof. William Goddard III
Show More
Exec. VP & CFO
Dr. Geoffrey Craig Porges MBBS
Exec. VP & Chief Information Officer
Mr. Shane Brauner
Sr. VP of Investor Relations & Corp. Communications
Ms. Jaren Irene Madden
Exec. VP, Chief Legal Officer & Sec.
Ms. Yvonne Tran Esq.
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one SDGR stock?

The intrinsic value of one SDGR stock under the Base Case scenario is 16.87 USD.

Is SDGR stock undervalued or overvalued?

Compared to the current market price of 16.49 USD, Schrodinger Inc is Undervalued by 2%.